These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9663704)

  • 1. Reconstituted recombinant factor VIII can be safely infused continuously for at least three days: it is a poor microbial growth medium.
    Didier ME; Fischer S; Maki DG
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):227-32. PubMed ID: 9663704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total nutrient admixtures appear safer than lipid emulsion alone as regards microbial contamination: growth properties of microbial pathogens at room temperature.
    Didier ME; Fischer S; Maki DG
    JPEN J Parenter Enteral Nutr; 1998; 22(5):291-6. PubMed ID: 9739032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability and sterility of a recombinant factor VIII concentrate prepared for continuous infusion administration.
    Belgaumi AF; Patrick CC; Deitcher SR
    Am J Hematol; 1999 Sep; 62(1):13-8. PubMed ID: 10467271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of recombinant factor VIII (Kogenate) stability for continuous infusion using a minipump infusion device.
    Hurst D; Zabor S; Malianni D; Miller D
    Haemophilia; 1998 Nov; 4(6):785-9. PubMed ID: 10028298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral infusions as culture media from a viewpoint of nosocomial bacteremia.
    Macías AE; Bruckner DA; Hindler JA; Muñoz JM; Medina H; Hernández I; Guerrero FJ
    Rev Invest Clin; 2000; 52(1):39-43. PubMed ID: 10818809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging Trends of Bloodstream Infections: A Six-Year Study at a Paediatric Tertiary Care Hospital in Kabul.
    Tariq TM; Rasool E
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):887-891. PubMed ID: 27981921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial viability in preparations packaged for single use.
    Obayashi A; Oie S; Kamiya A
    Biol Pharm Bull; 2003 May; 26(5):667-70. PubMed ID: 12736509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth of four microorganisms in polyethylene glycol-electrolyte lavage solution.
    Akly TS; DiPiro JT; Steele JC; Kemp GA
    Am J Hosp Pharm; 1986 Dec; 43(12):3013-6. PubMed ID: 3544827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterobacter cloacae and Pseudomonas aeruginosa polymicrobial bloodstream infections traced to extrinsic contamination of a dextrose multidose vial.
    Archibald LK; Ramos M; Arduino MJ; Aguero SM; Deseda C; Banerjee S; Jarvis WR
    J Pediatr; 1998 Nov; 133(5):640-4. PubMed ID: 9821421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growth of micro-organisms in intravenous fluids.
    Garcia-Caballero J; Herruzo-Cabrera H; Vera-Cortes ML; Garcia de Lorenzo A; Vazquez-Encinar A; Garcia-Caballero F; del Rey-Calero J
    J Hosp Infect; 1985 Jun; 6(2):154-7. PubMed ID: 2862189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions.
    Maki DG; Martin WT
    J Infect Dis; 1975 Mar; 131(3):267-72. PubMed ID: 236343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience.
    Schulman S; Varon D; Keller N; Gitel S; Martinowitz U
    Thromb Haemost; 1994 Sep; 72(3):403-7. PubMed ID: 7855792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life-threatening sepsis caused by Burkholderia cepacia from contaminated intravenous flush solutions prepared by a compounding pharmacy in another state.
    Held MR; Begier EM; Beardsley DS; Browne FA; Martinello RA; Baltimore RS; McDonald LC; Jensen B; Hadler JL; Dembry LM
    Pediatrics; 2006 Jul; 118(1):e212-5. PubMed ID: 16785290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of common bacteria and Candida albicans in 10% soybean oil emulsion.
    Deitel M; Kaminsky VM; Fuksa M
    Can J Surg; 1975 Nov; 18(6):531-5. PubMed ID: 830063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous catheter occlusion during continuous infusion of a new recombinant factor VIII concentrate].
    Takedani H; Abe Y; Kajiwara M; Kuwata A
    Rinsho Ketsueki; 2003 May; 44(5):339-41. PubMed ID: 12822410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.